Vol. 7, Issue 1, Part D (2025)

Liver cirrhosis is a long-term, progressive condition marked by severe scarring, the formation of regenerative nodules, and declining liver function, contributing to high rates of illness and death worldwide. It develops as a result of prolonged liver damage caused by factors such as chronic hepatitis infections, excessive alcohol use, metabolic disorders, and autoimmune diseases. The condition is driven by ongoing inflammation, abnormal collagen buildup, and changes in blood vessel structure, which ultimately disrupt the liver’s normal function. Detecting cirrhosis early is crucial to prevent life-threatening complications like portal hypertension, hepatic encephalopathy, and liver cancer. Fortunately, advanced non-invasive diagnostic tools, including elastography, biomarker analysis, and imaging techniques, have significantly improved the ability to assess and track liver damage. Current treatment strategies focus on managing the underlying causes, slowing the progression of the disease, and controlling complications. New pharmacological treatments, liver transplantation, and promising antifibrotic therapies provide hope for better outcomes. This review explores the mechanisms behind cirrhosis, advances in diagnosis, and emerging treatment options, highlighting the importance of early intervention and personalized approaches to improve patient care.